DE1219176B - Verfahren zur Herstellung von Arzneipraeparaten mit verzoegerter Wirkstoffabgabe - Google Patents

Verfahren zur Herstellung von Arzneipraeparaten mit verzoegerter Wirkstoffabgabe

Info

Publication number
DE1219176B
DE1219176B DEH47032A DEH0047032A DE1219176B DE 1219176 B DE1219176 B DE 1219176B DE H47032 A DEH47032 A DE H47032A DE H0047032 A DEH0047032 A DE H0047032A DE 1219176 B DE1219176 B DE 1219176B
Authority
DE
Germany
Prior art keywords
hour
tablets
polyethylene glycol
distearate
ingredients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DEH47032A
Other languages
German (de)
English (en)
Inventor
Jens Thuroe Carstensen
William Valentine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE1219176B publication Critical patent/DE1219176B/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DEH47032A 1961-10-20 1962-09-28 Verfahren zur Herstellung von Arzneipraeparaten mit verzoegerter Wirkstoffabgabe Pending DE1219176B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14642261A 1961-10-20 1961-10-20

Publications (1)

Publication Number Publication Date
DE1219176B true DE1219176B (de) 1966-06-16

Family

ID=22517286

Family Applications (1)

Application Number Title Priority Date Filing Date
DEH47032A Pending DE1219176B (de) 1961-10-20 1962-09-28 Verfahren zur Herstellung von Arzneipraeparaten mit verzoegerter Wirkstoffabgabe

Country Status (6)

Country Link
BE (1) BE623704A (fr)
DE (1) DE1219176B (fr)
ES (1) ES281704A1 (fr)
FR (1) FR2172M (fr)
GB (1) GB967610A (fr)
MY (1) MY6600083A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3217071A1 (de) * 1982-05-06 1983-11-10 Rüdiger Dr. 6365 Rosbach Gröning Arzneimittel fuer die perorale applikation mit verbesserter biologischer verfuegbarkeit der wirkstoffe

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK132572C (da) * 1971-11-17 1976-05-31 Colgate Palmolive Co Tandpasta
SE418247B (sv) * 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
US5082655A (en) * 1984-07-23 1992-01-21 Zetachron, Inc. Pharmaceutical composition for drugs subject to supercooling
US4629621A (en) * 1984-07-23 1986-12-16 Zetachron, Inc. Erodible matrix for sustained release bioactive composition
US4828857A (en) * 1984-10-05 1989-05-09 Warner-Lambert Company Novel sweetener delivery systems
US4797288A (en) * 1984-10-05 1989-01-10 Warner-Lambert Company Novel drug delivery system
US4804548A (en) * 1984-10-05 1989-02-14 Warner-Lambert Company Novel sweetener delivery systems

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2918411A (en) * 1957-11-01 1959-12-22 Olin Mathieson Pharmaceutical preparations

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2918411A (en) * 1957-11-01 1959-12-22 Olin Mathieson Pharmaceutical preparations

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3217071A1 (de) * 1982-05-06 1983-11-10 Rüdiger Dr. 6365 Rosbach Gröning Arzneimittel fuer die perorale applikation mit verbesserter biologischer verfuegbarkeit der wirkstoffe

Also Published As

Publication number Publication date
GB967610A (en) 1964-08-26
FR2172M (fr) 1963-11-25
ES281704A1 (es) 1963-04-16
BE623704A (fr)
MY6600083A (en) 1966-12-31

Similar Documents

Publication Publication Date Title
EP0959876B1 (fr) Procede pour separer des principes actifs dans des preparations pharmaceutiques solides
DE1948019C3 (de) Verfahren zur Herstellung von geformten Arzneizubereitungen mit Depotwirkung
DE2433285C2 (de) Mikrokapseln enthaltende Arzneimittel in Form einer Mehrschichttablette und Verfahren zu ihrer Herstellung
DE3915150C2 (de) Lang-wirkendes Diclofenac-Natrium-Präparat
DE3520184C2 (de) Neue galenische Retardform
EP0552227B1 (fr) Preparation pharmaceutique exempte de solvants, administree oralement, a liberation retardee du principe actif, ainsi que procede pour sa fabrication
DE3420283A1 (de) Nifedipin-trockenpraeparate und verfahren zu ihrer herstellung
DE1292783B (de) Verfahren zum Herstellen einer Tablette mit Depotwirkung
DE4332436A1 (de) Cyclosporin enthaltende pharmazeutische Zusammensetzungen
EP0068450A2 (fr) Formes pharmaceutiques pour administration orale
CH692321A5 (de) Pharmazeutisch wirksame Zusammensetzung, welche eine gegen Malariaparasiten wirksame Substanz enthält.
DE3126258A1 (de) Nicht bittere arzneimittelzubereitung und verfahren zu ihrer herstellung
DE2546577B2 (de) Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden
DE2706660A1 (de) Ascorbinsaeure enthaltende granulate und verfahren zu ihrer herstellung
DE1219176B (de) Verfahren zur Herstellung von Arzneipraeparaten mit verzoegerter Wirkstoffabgabe
DE3524003A1 (de) Arzneimittelgranulat mit verzoegerter wirkstofffreisetzung und verfahren zu seiner herstellung
DE3541304A1 (de) Orale zubereitungen von knoblauch und verfahren zu ihrer herstellung
EP1847258B1 (fr) Compositions pharmaceutiques comprenant thieno[3,2-c]pyridine comme agent active et des glycérols partielles comme lubrifiante
DD202502A5 (de) Verfahren zur herstellung einer arzneiform mit verbesserter magenvertraeglichkeit
DE2425764A1 (de) Tabletten
DE2439538B2 (de) Verfahren zur Herstellung von oral zu verabreichenden Arzneimitteln mit verzögerter Wirkungsfreigabe
DE1766546A1 (de) Verfahren zur Herstellung von Arzneipillen oder Tabletten
DE1667062A1 (de) Verfahren zur Herstellung kleiner kugelfoermiger Perlen
AT232648B (de) Verfahren zur Herstellung einer Arzneimittelzubereitung mit verzögerter Wirkstoff-Freisetzung
DE2148391A1 (de) Arzneimittel mit verlängerter Wirk stoffabgabe